A first step toward liposome-mediated intracellular bacteriophage therapy

Expert Opinion on Drug Delivery

Volumn 12, Issue 9, 2015, Pages 1411-1424

  Nieth, Anita ^a   Verseux, Cyprien ^b,c   Barnert, Sabine ^a   Süss, Regine ^a   Römer, Winfried ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c NASA AMES RESEARCH CENTER   (United States)

Author keywords

antibiotic resistance; bacteriophage therapy; intracellular pathogens; liposomes; trafficking; tuberculosis

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VECTOR; LIPOSOME; ANTIINFECTIVE AGENT;

ANIMAL CELL; ARTICLE; BACTERIOPHAGE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; ENCAPSULATION; ENDOCYTOSIS; EUKARYOTIC CELL; IN VITRO STUDY; LIPOSOMAL DELIVERY; LIPOSOME MEMBRANE; MAMMAL CELL; MYCOBACTERIOPHAGE; NONHUMAN; PATHOGENESIS; PHAGE DISPLAY; BACTERIUM; CELL LINE; DRUG EFFECTS; HUMAN; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIOPHAGES; CELL LINE; HUMANS; LIPOSOMES; TUBERCULOSIS;

EID: 84939616290     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2015.1043125     Document Type: Article

References (59)

1. Beović B. The issue of antimicrobial resistance in human medicine. Int J Food Microbiol 2006; 112: 280-7
2. WHO Fact sheet No 194: Antimicrobial resistance. Available from: http://www.who.int/mediacentre/factsheets/fs194/en/. [Last accessed 26 June 2014]
3. DHerelle F. An invisible microbe that is antagonistic to the dysentery bacillus. Comptes Rendus Acadamie des Sciences 1917; 165: 373-5
4. Summers WC. The strange history of phage therapy. Bacteriophage 2012; 2: 130-3
5. Sulakvelidze A, Alavidze Z, Morris JG. Bacteriophage Therapy. Antimicrob Agents Chemother 2001; 45: 649-59
6. Summers WC. Bacteriophage Therapy. Annu Rev Microbiol 2001; 55: 437-51
7. Dublanchet A, Fruciano E. A short history of phage therapy. Med Mal Infect 2008; 38: 415-20. Article in French
8. Verbeken G, Huys I, Pirnay J-P, et al. Taking bacteriophage therapy seriously: a moral argument. Biomed Res Int 2014; 10.1155/2014/621316
9. Hanlon GW. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents 2007; 30: 118-28
10. Ojala V, Laitalainen J, Jalasvuori M. Fight evolution with evolution: plasmid-dependent phages with a wide host range prevent the spread of antibiotic resistance. Evol Appl 2013; 6: 925-32
11. Chan BK, Abedon ST, Loc-Carillo C. Phage cocktails and the future of phage therapy. Future Microbiol 2013; 8 (6): 769-83
12. Nilsson AS. Phage therapy-constraints and possibilities. Ups J Med Sci 2014; 119 (2): 192-8
13. WHO Fact sheet No 104: Tuberculosis. Available from: http://www.who.int/mediacentre/factsheets/fs104/en/index.html. [Last accessed 03 March 2014]
14. Dubos RJ, Straus JH, Pierce C. The multiplication of bacteriophages in vivo and its protective effect against an experimental infection with Shigella dysenteriae. J Exp med 1943; 20: 161-8
15. Dabrowska K, Switała-Jelen K, Opolski A, et al. Bacteriophage penetration in vertebrates. J Appl Microbiol 2005; 98: 7-13
16. Morello E, Saussereau E, Maura D, et al. Pulmonary bacteriophage therapy of Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS One 2011; 6 (2): e16963
17. McNerney R. The return of the phage. A review of fifty years of mycobacteriophage research. Int J Tuberc Lung Dis 1999; 3: 179-84
18. Sula L, Sulová J, Stolcpartová M. Therapy of experimental tuberculosis in guinea pigs with mycobacterial phages DS-6A, GR-21 T, My-327. Czech Med 1981; 4: 209-14
19. Peng L, Chen B, Luo Y, et al. Effect of mycobacteriophage to intracellular mycobacteria in vitro. Chin Med J 2006; 119 (8): 692-5
20. Capparelli R, Parlato M, Borriello G, et al. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother 2007; 51 (8): 2765-73
21. Emery DL, Whittington RJ. An evaluation of mycophage therapy, chemotherapy and vaccination for control of Mycobacterium avium subsp. paratuberculosis infection. Vet microbiol 2004; 104 (3-4): 143-55
22. Johnston N. Viral Trojan horse for combating tuberculosis. Drug Discov Today 2002; 7 (6): 333-5
23. Broxmeyer L. Bacteriophages: antibacterials with a future? Med Hypotheses 2004; 62 (6): 889-93
24. Broxmeyer L, Sosnowska D, Miltner E, et al. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: A Model for Phage Therapy of Intracellular Bacterial Pathogens. J Infect Dis 2002; 186 (8): 1155-60
25. Danelishvili L, Young LS, Bermudez LE. In vivo efficacy of phage therapy for mycobacterium avium infection as delivered by a nonvirulent mycobacterium. Microb Drug Resist 2006; 12 (1): 1-6
26. Nieth A, Verseux C, Römer W. A question of attire-dressing up bacteriophage therapy for the battle against antibiotic-resistant intracellular bacteria. Springer Science Reviews 2014; 10.1007/s40362-014-0027-x
27. Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013; 65 (1): 36-48
28. Owais M, Gupta CM. Targeted drug delivery to macrophages in parasitic infections. Curr Drug Deliv 2005; 2 (4): 311-18
29. Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J Pharm 1997; 154: 123-40
30. Puapermpoonsiri U, Spencer J, van der Walle CF. A freeze-dried formulation of bacteriophage encapsulated in biodegradable microspheres. Eur J Pharm Biopharm 2009; 72 (1): 26-33
31. Lameiro MH, Malpique R, Silva AC, et al. Encapsulation of adenoviral vectors into chitosan-bile salt microparticles for mucosal vaccination. J Biotechnol 2006; 126 (2): 152-62
32. Offit PA, Khoury CA, Moser CA, et al. Enhancement of rotavirus immunogenicity by microencapsulation. Virology 1994; 203 (1): 134-43
33. Moser CA, Speaker TJ, Offit PA. Effect of water-based microencapsulation on protection against EDIM rotavirus challenge in mice. J Virol 1998; 72 (5): 3859-62
34. Ma Y, Pacan JC, Wang Q, et al. Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery. Appl Environ Microbiol 2008; 74 (15): 4799-805
35. Lee SW, Belcher AM. Virus-based fabrication of micro-and nanofibers using electrospinning. Nano Lett 2004; 4 (3): 387-90
36. Salalha W, Kuhn J, Dror Y, et al. Encapsulation of bacteria and viruses in electrospun nanofibres. Nanotechnology 2006; 17: 4675-81
37. Korehei R, Kadla JF. Encapsulation of T4 bacteriophage in electrospun poly(ethylene oxide)/cellulose diacetate fibers. Carbohydr Polym 2014; 100: 150-7
38. Schäfer R, Huber U, Franklin RM. Chemical and physical properties of mycobacteriophage D29. Eur J Biochem 1976; 73 (1): 239-46
39. Timme TL, Brennan PJ. Induction of bacteriophage from members of the Mycobacterium avium, Mycobacetrium intracellulare, Mycobacterium scrofulaceum serocomplex. J Gen Microbiol 1984; 130 (8): 2059-66
40. Reeves JP, Dowben RM. Formation and properties of thin-walled phospholipid vesicles. J Cell Physiol 1969; 73: 49-60
41. Angelova MI, Dimitrov DS. Liposome electroformation. Faraday Discuss Chem Soc 1986; 81: 303-11
42. Buboltz JT, Feigenson GW. A novel strategy for the preparation of liposomes: rapid solvent exchange. Biochim Biophys Acta 1999; 1417: 232-45
43. Pautot S, Frisken B, Weitz DA. Engineering asymmetric vesicles. PNAS 2003; 100 (19): 10718-21
44. Weinberger A, Tsai F-C, Koenderink GH, et al. Gel-assisted formation of giant unilamellar vesicles. Biophys J 2013; 105 (1): 154-64
45. Rohde K, Yates RM, Purdy GE, et al. Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev 2007; 8 (11): 1261-72
46. Welin A, Lerm M. Inside or outside the phagosome? The controversy of the intracellular localization of Mycobacterium tuberculosis. Tuberculosis 2012; 92 (2): 113-20
47. Un K, Sakai-Kato K, Oshima Y, et al. Intracellular trafficking mechanism, from intracellular uptake to extracellular efflux, for phospholipid/cholesterol liposomes. Biomaterials 2012; 33 (32): 8131-41
48. Alvarez LJ, Thomen P, Makushok T, et al. Propagation of fluorescent viruses in growing plaques. Biotechnol Bioeng 2007; 96 (3): 615-21
49. Kropinski AM, Mazzocco A, Waddell TE, et al. Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol Biol 2009; 501: 69-76
50. Pontani LL, van der Gucht J, Salbreux G, et al. Reconstitution of an actin cortex inside a liposome. Biophys J 2009; 96: 192-8
51. Globule size distribution in lipid injectable emulsions. United States Pharmacopeia and National Formulary (USP 32-NF 27). United States Pharmacopeia Convention, Rockville, MD; 2007. p. 3968-70
52. Lauber K, Blumenthal SG, Waibel M, et al. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 2004; 14: 277-87
53. Dominak LM, Keating CD. Polymer encapsulation within giant lipid vesicles. Langmuir 2007; 23: 7148-54
54. Dominak LM, Omiatek DM, Gundermann EL, et al. Polymeric crowding agents improve passive biomacromolecule encapsulation in lipid vesicles. Langmuir 2010; 26 (16): 13195-200
55. Golshahi L, Lynch KH, Dennis JJ, et al. In vitro lung delivery of bacteriophages KS4-M and φKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis. J Appl Microbiol 2010; 110 (1): 106-17
56. Römer W, Pontani LL, Sorre B, et al. Actin dynamics drive membrane reorganization and scission in clathrin.independent endocytosis. Cell 2010; 140 (4): 540-53
57. Theus SA, Cave MD, Eisenach KD. Activated THP-1 cells: an attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates. Infect Immun 2004; 72 (2): 1169-73
58. van der Wel N, Hava D, Houben D, et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 2007; 129: 1287-98
59. Schnupf P, Portnoy DA. Listeriolysin O: a phagosome-specific lysin. Microbes Infect 2007; 9: 1176-87